Herpes simplex virus vaccines as immunotherapeutic agents.
As persistent viruses can escape immune surveillance, chronic or recurrent disease can be a major problem. Only after nearly 60 years of work have recent reproducible data, using herpes simplex virus infection as a model for persistent viral disease, established that vaccine immunotherapy is effective in the treatment of such viral infections.